Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Fibrinogen

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Grifols preps blood clot treatment approval push after ph. 3 win
    Grifols preps blood clot treatment approval push after ph. 3 win

    15 Feb 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/drug-delivery/grifols-readies-us-eu-approval-push-blood-clot-treatment-after-phase-3-success

    FIERCE PHARMA
    15 Feb 2024
    Share Share
    EMA Assessmt & Procedural Steps for Mallinckrodt's Raplixa (human fibrinogen)
    EMA Assessmt & Procedural Steps for Mallinckrodt's Raplixa (human fibrinogen)

    10 Oct 2018

    // EMA

    https://www.ema.europa.eu/documents/procedural-steps-after/raplixa-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf

    EMA
    10 Oct 2018
    Share Share
    EMA Statement on Withdrawing Mallinckrodt's Raplixa (human fibrinogen)
    EMA Statement on Withdrawing Mallinckrodt's Raplixa (human fibrinogen)

    10 Oct 2018

    // EMA

    https://www.ema.europa.eu/documents/public-statement/public-statement-raplixa-withdrawal-marketing-authorisation-european-union_en-0.pdf

    EMA
    10 Oct 2018
    Share Share
    EMA Withdraws Authorisation of Mallinckrodt Pharma's Raplixa (human fibrinogen)
    EMA Withdraws Authorisation of Mallinckrodt Pharma's Raplixa (human fibrinogen)

    10 Oct 2018

    // EMA

    https://www.ema.europa.eu/documents/product-information/raplixa-epar-product-information_en.pdf

    EMA
    10 Oct 2018
    Share Share
    Instituto Grifols, S.A. VeraSeal (human fibrinogen / human thrombin) Receives Approval In Europe
    Instituto Grifols, S.A. VeraSeal (human fibrinogen / human thrombin) Receives Approval In Europe

    19 Jan 2018

    // EMA

    https://www.pharmacompass.com/pdf/news/instituto-grifols-sa-veraseal-human-fibrinogen-human-thrombin-receives-approval-in-europe-1516426069.pdf

    EMA
    19 Jan 2018
    Share Share